Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction

Circulation Journal

Volumn 72, Issue 9, 2008, Pages 1425-1429

  Han, Cheol Lee ^a,b   Sung, Gyu An ^a   Choi, Jae Hoon ^a   Tae, Kun Lee ^a   Kim, Jun ^a   June, Hong Kim ^a   Kook, Jin Chun ^a   Taek, Jong Hong ^a   Yung, Woo Shin ^a   Lee, Sang Kwon ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Ischemic preconditioning; Myocardial infarction; Nicorandil; Reperfusion injury

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRATE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; INCIDENCE; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CORONARY CIRCULATION; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NICORANDIL; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 50449110902     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0212     Document Type: Article

References (22)

1. Ito H, Taniyama Y, Iwakura K, Nishikawa N, Masuyama T, Kuzuya T, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654- 660.
2. Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, Okamoto S, et al. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). Circ J 2006; 70: 1099-1104.
3. Ikeda N, Yasu T, Kubo N, Hashimoto S, Tsuruya Y, Fujii M, et al. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart 2004; 90: 181-185.
4. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993; 21: 537-545.
5. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models. Am J Cardiol 1993; 72: 13G-21G.
6. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: The Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002; 359: 1269-1275.
7. Lim SY, Bae EH, Jeong MH, Kim HG, Lim JH, Park HW, et al. The clinical effect of intracoronary adenosine and nicorandil on no-reflow in acute myocardial infarction during percutaeous coronary intervention. Korean Circ J 2004; 34: 258-264.
8. Auchampach JA, Cavero I, Gross GJ. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol 1992; 20: 765-771.
9. Mizumura T, Nithipatikom K, Gross GJ. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res 1995; 29: 482-489.
10. Galie N, Guarnieri C, Ussia GP, Zimarino M, Traini AM, Parlangeli R, et al. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol 1995; 26: 477-484.
11. Pieper GM, Gross GJ. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther 1992; 6: 225-232.
12. Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, et al. Vasodilatory effect of nicorandil on coronary arterial microvessels: Its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol 1995; 26: 541-547.
13. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomised trials. Lancet 2007; 370: 1483-1493.
14. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005; 112: 1284-1288.
15. Sakata Y, Kodama K, Komamura K, Lim YJ, Ishikura F, Hirayama A, et al. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction. Am Heart J 1997; 133: 616-621.
16. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De RaedtH, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: Importance of microvascular reperfusion injury on clinical outcome. Circulation 1999; 99: 1972-1977.
17. Aiello EA, Jabr RI, Cole WC. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia: Role of oxygen radical-induced no-reflow phenomenon. Circ Res 1995; 77: 153-162.
18. Ito H. No reflow phenomenon in coronary heart disease. J Cardiol 2001; 37(Suppl): 39-42.
19. De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. JAMA 2005; 293: 1759-1765.
20. Neumann FJ, Blasini R, Schmitt C, Alt E, Dirschinger J, Gawaz M, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998; 98: 2695-2701.
21. Hayashi T, Ichikawa M, Iwata A, Nakata T, Lim YJ, Mishima M. Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse. Circ J 2008; 72: 327-330.
22. Zhu WL, Shan YD, Guo JX, Wei JP, Yang XC, Li TD, et al. Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China. Circ J 2007; 71: 826-833.